The increasing interest in effective weight management has led to considerable investigation into novel treatments. Recently , Retatrutide, a twin-action glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor activator , has demonstrated positive results in patient trials, indicating potential for considerable weight loss . As a resu